<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Fatal anaphylaxis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Fatal anaphylaxis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Fatal anaphylaxis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            S Allan Bock, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John M Kelso, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anna M Feldweg, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 28, 2021.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. It has been estimated to be fatal in 0.7 to 2 percent of cases [
         <a href="#rid1">
          1,2
         </a>
         ]. In humans, fatal anaphylaxis is difficult to study because it is rare, unpredictable, and often unwitnessed. In addition, there may be few postmortem findings and laboratory tests may be negative.
        </p>
        <p>
         This topic will review the incidence, etiologies, epidemiology, clinical characteristics, possible risk factors, and postmortem diagnosis of fatal anaphylaxis as they pertain to these fundamental questions. The diagnosis and management of anaphylaxis in adults is presented separately [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/386.html" rel="external">
          "Pathophysiology of anaphylaxis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          INCIDENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The annual incidence of fatal anaphylaxis is not known precisely, although available estimates are less than one per million in the population [
         <a href="#rid4">
          4-13
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A study of anaphylaxis deaths in the United States found annual rates of 0.21 to 0.76 per million [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Centralized registries of fatal anaphylactic reactions from all causes have been established in the United Kingdom, France, and some other countries [
         <a href="#rid6">
          6,7
         </a>
         ]. In the United Kingdom, one case of fatal anaphylaxis per three million individuals yearly (approximately 20 deaths a year) has been reported [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2016 study from Australia found that rates of fatal anaphylaxis increased from 0.054 to 0.099 per million individuals from 1997 to 2013 [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A study from New Zealand estimated the rate to be approximately one per million [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Studies have drawn conflicting conclusions about whether the incidence of fatal anaphylaxis is changing over time [
         <a href="#rid6">
          6,9,11,14-17
         </a>
         ]. The largest study available, from a French database, concluded that anaphylaxis deaths in that country were decreasing at a rate of 2 percent per year [
         <a href="#rid12">
          12
         </a>
         ]. Another study found that drug-induced anaphylaxis was increasing in several countries, while anaphylaxis from other causes was stable [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         Studies of fatal anaphylaxis caused by food-allergic reactions specifically are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2401.html" rel="external">
          "Food-induced anaphylaxis", section on 'Fatal reactions'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H27047963">
         <span class="h2">
          Case fatality rate
         </span>
         <span class="headingEndMark">
          —
         </span>
         Case fatality rates in the United States for patients treated for anaphylaxis (from all causes) either in the emergency department or hospital were estimated using three national databases and found to be between 0.25 and 0.33 percent, representing 63 to 99 deaths annually [
         <a href="#rid5">
          5
         </a>
         ]. Thus, the prognosis for patients diagnosed and treated in these settings is relatively favorable. Mortality rates were highest in older male adults and lowest in children.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Possible underdiagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fatal anaphylaxis may be underdiagnosed because of the absence of specific findings at autopsy and lack of definitive diagnostic tests [
         <a href="#rid19">
          19-21
         </a>
         ]. Examples of situations in which anaphylaxis is likely overlooked as the cause of death include the following [
         <a href="#rid6">
          6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Asthmatic patients (especially children and adolescents) with concomitant food allergy may suffer food-induced anaphylaxis with prominent respiratory symptoms and be misdiagnosed as having a fatal asthma attack. It is therefore important to remind all patients with food allergy and asthma to think about what food they might have eaten when they have the abrupt onset of asthma without a clear trigger. This may be especially important when the asthma episode does not respond to the individual's usual treatment in the usual manner.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Older adults with chronic pulmonary disease may die at home from antibiotic-induced anaphylaxis and be misdiagnosed as a cardiac or respiratory arrest due to either the chronic condition or the recent infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unrecognized insect stings may cause collapse and sudden death and be misdiagnosed as cardiovascular events, particularly if anaphylaxis involved myocardial ischemia or an arrhythmia. The cardiovascular aspects of anaphylaxis are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/386.html" rel="external">
          "Pathophysiology of anaphylaxis", section on 'Cardiovascular system'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          ETIOLOGIES AND AT-RISK GROUPS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fatal anaphylaxis can occur following a variety of triggers, although the most common culprits are medications, insect stings, and foods [
         <a href="#rid12">
          12
         </a>
         ]. Approximately one-half of all anaphylactic fatalities each year in the United Kingdom register were attributable to medications or agents administered during medical procedures (such as contrast media) [
         <a href="#rid6">
          6
         </a>
         ]. Reactions to foods and insect venoms each accounted for nearly one-quarter of the total cases, with other causes accounting for the remaining cases.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Beta-lactam antibiotics (ie, penicillins and cephalosporins) appear to cause more fatalities than other drugs [
         <a href="#rid8">
          8,18,22
         </a>
         ]. Multiple other agents have been implicated in smaller numbers of cases, including the following [
         <a href="#rid6">
          6,10,22-26
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Radiocontrast agents
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neuromuscular blockers and anesthetics
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allergen immunotherapy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other antibiotics
        </p>
        <p>
        </p>
        <p>
         Adults are more often affected by medication-induced anaphylaxis, compared with children or adolescents [
         <a href="#rid9">
          9,17,27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Foods
         </span>
         <span class="headingEndMark">
          —
         </span>
         Peanuts and tree nuts account for the majority of food-induced fatalities [
         <a href="#rid6">
          6,28-31
         </a>
         ]. Cow's milk and seafood are also leading causes of severe and fatal reactions [
         <a href="#rid32">
          32
         </a>
         ]. A variety of other foods have been implicated less commonly. At least two cases of fatal food-induced, exercise-associated anaphylaxis have been reported, although exercise or exertion is likely an unrecognized cofactor in other food-induced deaths [
         <a href="#rid33">
          33,34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2398.html" rel="external">
          "Clinical manifestations of food allergy: An overview"
         </a>
         .)
        </p>
        <p>
         Adolescents and young adults are the most frequent victims of fatal food-induced anaphylaxis [
         <a href="#rid8">
          8,17,30
         </a>
         ]. The following were observed in the United Kingdom register over a 10-year period [
         <a href="#rid8">
          8
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fatal cow's milk reactions affected mostly children (median age was 8 years).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fatal peanut reactions affected mostly young adults (median age was 21 years).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fatal tree nut reactions affected mostly adults (median age was 27 years).
        </p>
        <p>
        </p>
        <p>
         The reasons for the higher rate of food-induced deaths in adolescents and young adults are not clear. Risk-taking behaviors related to cognitive and emotional development are likely contributing factors. In an internet-based anonymous survey of 176 adolescents and young adults with food allergy, more than one-half reported purposefully ingesting a potentially unsafe food, and 17 percent reported both eating foods that "may contain" allergens and not consistently carrying
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
         The one reported case of fatal anaphylaxis due to a food challenge occurred in a young child receiving baked milk [
         <a href="#rid36">
          36
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2399.html" rel="external">
          "Oral food challenges for diagnosis and management of food allergies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Insect stings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stings of Hymenoptera species (yellow jacket, honey bee, wasp, hornet, and imported fire ants) are one of the three leading causes of fatal anaphylaxis in the United States and United Kingdom [
         <a href="#rid37">
          37-41
         </a>
         ]. Adults make up the majority of victims in venom-induced fatal anaphylaxis, with a peak incidence in patients 45 to 70 years [
         <a href="#rid12">
          12,42
         </a>
         ]. Men are stung more often, perhaps due to higher rates of outdoor occupations. Older adults may be at increased risk for venom-induced death as well [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4091.html" rel="external">
          "Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4092.html" rel="external">
          "Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Other causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other reported causes of fatal anaphylaxis include latex, rupture of a hydatid cyst, infestation with the parasite
         <em>
          Taenia solium
         </em>
         , dental impression material, and the herbal preparation
         <em>
          Houttuynia cordata
         </em>
         [
         <a href="#rid6">
          6,43-47
         </a>
         ]. In some cases, no cause can be identified and the etiology is designated idiopathic [
         <a href="#rid8">
          8,48,49
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Individuals of any age can develop anaphylaxis, and fatalities have been reported in infants as young as 5 months and in adults as old as 91 years [
         <a href="#rid27">
          27,29
         </a>
         ]. Certain trends are detectable, however. Adolescents and young adults are at highest risk for fatal anaphylaxis from foods, middle-aged adults are the most frequent victims of venom-induced deaths, and older adults account for most cases of fatal medication-induced anaphylaxis.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Location
         </span>
         <span class="headingEndMark">
          —
         </span>
         Case series reveal that fatal food reactions occur in the patient's home, the homes of friends, restaurants, work/office settings, and schools [
         <a href="#rid6">
          6,28,29,31
         </a>
         ]. Most food-induced anaphylaxis is triggered by food that was not prepared by the patients themselves [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         High-risk foods for patients with peanut and tree nut allergies include baked goods, candy, and desserts. Issues pertaining to food allergen exposure are reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2406.html" rel="external">
          "Management of food allergy: Avoidance"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5739.html" rel="external">
          "Food allergy in schools and camps"
         </a>
         .)
        </p>
        <p>
         Fatal stings can be sustained outdoors or indoors. Although outdoor occupations are often cited as a possible explanation for the predominance of male victims, a 10-year United Kingdom registry reported that only 15 percent of stings occurred at work, while 32 percent occurred in the patient's yard and 39 percent occurred inside the home (including 5 percent in bed) [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         Medication-induced fatal anaphylaxis often occurs in a medically-supervised setting:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Most reported fatal anaphylactic reactions to medications and contrast agents occur in the hospital setting, which may reflect the wider range of agents used in this environment, higher rates of intravenous administration, or patient-related factors [
         <a href="#rid10">
          10,51
         </a>
         ]. General anesthesia was associated with more fatalities than other hospital procedures in one series [
         <a href="#rid50">
          50
         </a>
         ]. Alternatively, it is possible that community cases are under-recognized and under-reported. (See
         <a class="local">
          'Possible underdiagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fatal anaphylactic reactions to allergen immunotherapy occur approximately once per 2.5 million injections administered and account for three to four deaths per year in the United States [
         <a href="#rid26">
          26
         </a>
         ]. These reactions are most prevalent in the 20 to 30 minutes immediately following administration, and most allergists require patients to wait this amount of time in the clinic after each set of injections [
         <a href="#rid25">
          25
         </a>
         ]. Rare deaths still occur despite this precaution.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3181845618">
         <span class="h2">
          Sex
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is not clear if sex contributes to the risk for fatal anaphylaxis, although some trends have been noted. As examples, the sex ratio is approximately equal for food anaphylaxis overall. However, young boys are affected more by fatal cow's milk reactions, and adolescent girls are affected more by peanut reactions [
         <a href="#rid8">
          8,28,50
         </a>
         ]. Fatalities from contrast media and insect stings appear to affect males more than females [
         <a href="#rid52">
          52,53
         </a>
         ]. In a large French series of 1603 deaths, men had an increased risk [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1116341392">
         <span class="h2">
          Race
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of ethnicities have been represented in studies of anaphylaxis. However, there are not enough data to determine if racial differences in mortality exist.
        </p>
        <p class="headingAnchor" id="H824086568">
         <span class="h2">
          Registries
         </span>
         <span class="headingEndMark">
          —
         </span>
         Worldwide, anaphylaxis registries are being established to gather information about anaphylaxis from various causes, some of which are specific to fatal cases:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.nationalfoodallergydeathregistry.org%2Fthe-registry&amp;token=2nfTwVBGBSlVWLuqQQvl4txgAwyzE6kqmcOGUX1ZPpL9EZ5nf2jiD%2BBUv%2BZuc5Z55%2F6r2k0P7VtWyMvZWyBoBg%3D%3D&amp;TOPIC_ID=390" target="_blank">
          National Food Death Allergy Registry
         </a>
         (an online registry of individuals who suffered fatal food-induced anaphylaxis in the United States)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.anaphylaxie.net%2Fen%2F&amp;token=%2BCjrhIBVW0jZK35njTvgcXLgmN0aAWB2O9vNmmrsfriuFeo3wzj0LQpH4cOLR%2BVy&amp;TOPIC_ID=390" target="_blank">
          A European database
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         UK Fatal Anaphylaxis Register (not available online)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cross-Canada Anaphylaxis Registry (C-CARE) (maintained by the Allergy, Genes, and Environment Network)
        </p>
        <p>
        </p>
        <p>
         Several other countries are also tracking anaphylaxis and anaphylaxis fatalities but have not established formal registries.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          CLINICAL CHARACTERISTICS OF FATAL REACTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Case reports and series have provided valuable information about the clinical characteristics of fatal anaphylactic reactions.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Previous reactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Victims of fatal anaphylaxis may not be aware that they are allergic to the implicated allergen [
         <a href="#rid54">
          54
         </a>
         ]. In one series of 25 fatalities, the history of a previous reaction could be elicited from the patient's relatives or medical records in just one-third of cases [
         <a href="#rid27">
          27
         </a>
         ]. Even in patients with known past reactions, the severity of previous reactions cannot be relied upon to predict the severity of future reactions, a finding which has been noted in multiple series [
         <a href="#rid6">
          6,28-31,42,48
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In fatal food anaphylaxis, most individuals did have previous reactions to the culprit food and were supposed to be avoiding it. In many cases, however, these reactions were so mild that it is unlikely that most clinicians would have advised the patient to carry an
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         autoinjector. It is possible that these patients represent an unfortunate minority whose initial severe reaction proved fatal. Perhaps other patients' symptoms escalated gradually, prompting them to seek medical evaluation and thus be better prepared for re-exposure. The frequency of these different patterns is not known.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In contrast, victims of venom- and medication-induced anaphylaxis often had no known history of a previous reaction. In many cases of venom anaphylaxis, the individual was stung in the past and did not have systemic symptoms [
         <a href="#rid50">
          50
         </a>
         ]. Similarly, no history of previous reactions to the causative medication can be elicited in some drug-induced fatalities [
         <a href="#rid6">
          6,50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Timing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Less than 60 minutes elapses between allergen exposure and death in most cases of fatal anaphylaxis [
         <a href="#rid8">
          8,30
         </a>
         ]. Most fatal reactions are uniphasic, present fulminantly, and progress rapidly, although a few follow a more protracted or biphasic course, typically over several hours [
         <a href="#rid30">
          30,55,56
         </a>
         ].
        </p>
        <p>
         An analysis of 202 fatalities over a 10-year period in the United Kingdom determined that the interval between exposure and the onset of symptoms varied with the type of allergen and route of exposure, as follows [
         <a href="#rid6">
          6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Following medications, symptoms appeared after a mean of 5 minutes in hospitalized patients and after 10 to 20 minutes in ambulatory patients.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Following insect stings, symptoms appeared after a mean of 10 to 15 minutes.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Following foods, symptoms appeared after 25 to 35 minutes.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Allergen dose
         </span>
         <span class="headingEndMark">
          —
         </span>
         It seems logical that the higher the allergen dose, the more rapid and severe the reaction, although patients may have very different threshold levels beyond which they will experience anaphylaxis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fatal food anaphylaxis has been reported in response to a wide range of allergen doses, from trace amounts to doses in excess of 100 grams. In keeping with the impression that nuts are especially potent allergens, one review found that the dose of nuts that was most frequently implicated in fatalities was approximately 1 gram, while the dose most often reported in fatal anaphylaxis from other foods was about 10 grams [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Most insect sting fatalities result from a single sting [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Most drug-induced fatalities occur in response to normal doses of the culprit medication [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          MECHANISM OF DEATH
         </span>
         <span class="headingEndMark">
          —
         </span>
         Respiratory arrest and/or shock with cardiovascular collapse are responsible for most fatalities [
         <a href="#rid57">
          57,58
         </a>
         ]. The mechanism of death appears to be determined, at least in part, by the type of allergen. In a review of 56 cases of fatal anaphylaxis for which autopsy data were available, all food-induced reactions involved difficulty breathing, and respiratory arrest was the mechanism of death in 13 of 16 cases [
         <a href="#rid51">
          51
         </a>
         ]. In contrast, shock without respiratory compromise was the presentation in most cases of venom- or medication-induced anaphylaxis [
         <a href="#rid59">
          59
         </a>
         ]. This correlation between allergen type and mechanism of death has been noted in many studies and is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/386.html" rel="external">
          "Pathophysiology of anaphylaxis"
         </a>
         .)
        </p>
        <p>
         In a very small number of cases, massive
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         overdose or disseminated intravascular coagulation appeared to be the immediate cause of death [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          POSSIBLE RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most consistently noted risk factor for fatal anaphylaxis is concomitant asthma. Other possible risk factors include delayed or no administration of
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         , upright posture, and other cardiopulmonary diseases  (
         <a class="graphic graphic_table graphicRef76871" href="/z/d/graphic/76871.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Asthma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asthma may be the single most important risk factor for fatal food-induced anaphylaxis. In the 10-year United Kingdom series, all fatal food reactions occurred in patients taking daily medications for asthma [
         <a href="#rid50">
          50
         </a>
         ]. Although guidelines state that all patients with daily symptoms should be treated with inhaled glucocorticoids, many were not taking these agents, and some were using short-acting beta-agonists excessively. In another series of 32 food-induced fatalities, all but one patient had asthma [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Asthma also appears to be common among victims of drug- and venom-induced anaphylaxis, although the correlation is not as strong as that for food [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         It is not known if controlling asthma reduces the risk of death from anaphylaxis. Most series have not reported the status of the individual's asthma at the time of his/her death, but the study above implies that at least some patients have poorly-controlled symptoms [
         <a href="#rid50">
          50
         </a>
         ]. In contrast, one study of 13 fatal or near-fatal food reactions reported that 12 patients had asthma that was well-controlled [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Delayed or no administration of epinephrine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early administration of
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         appears to be critical for survival after severe anaphylaxis. A series of 13 fatal and near-fatal food-induced anaphylactic reactions in children and adolescents suggested that epinephrine is most effective when given in the initial 30 minutes of the reaction [
         <a href="#rid30">
          30
         </a>
         ]. Epinephrine was administered within this time period in six of seven children who survived, whereas only two of six patients who died received the drug within the first hour.
        </p>
        <p>
         Several series have found that only a minority of individuals with fatal anaphylaxis receive
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         promptly or at all [
         <a href="#rid6">
          6,27,30
         </a>
         ]. A United Kingdom series of anaphylactic deaths occurring from 1992 to 1998 found that only 20 percent of patients were given epinephrine at any point in their treatment [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         The number of food- and venom-allergic individuals who do not carry their prescribed self-injectable
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         is large and discouraging. Furthermore, many of those who do carry it are unable to self-administer it promptly and correctly in a panic situation because they have not been instructed in how to use the device or have not practiced with the trainer.
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h2">
          No response to epinephrine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Even when
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         is available and administered without delay, it is not always effective for a number of reasons  (
         <a class="graphic graphic_table graphicRef61580" href="/z/d/graphic/61580.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid60">
          60
         </a>
         ]. There are reports of anaphylaxis, typically during medical procedures, in which the victim succumbed despite receiving appropriate treatment, including prompt administration of epinephrine. Thus, both clinicians and patients should understand that the recommended management of anaphylaxis is not universally effective.
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Other cardiopulmonary disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other cardiac or pulmonary conditions are identified in a significant proportion of middle- and older-aged patients who succumb to anaphylaxis from all causes [
         <a href="#rid6">
          6,27,61
         </a>
         ]. In one study, 88 percent of victims had one or more comorbid conditions, including 11 of 25 with symptomatic ischemic heart disease, as well as others with heart failure, hypertensive heart disease, and chronic obstructive pulmonary disease [
         <a href="#rid27">
          27
         </a>
         ]. Other series found lower rates of concomitant diseases, although cardiac and pulmonary conditions consistently predominated [
         <a href="#rid10">
          10,27,51
         </a>
         ].
        </p>
        <p>
         It is biologically plausible that these comorbid conditions directly contribute to the fatal outcome, as the heart and lungs are the primary shock organs in anaphylaxis and could be expected to fail more readily if compromised by pre-existing disease. It is also possible that patients with cardiac disease are at increased risk for adverse reactions to treatment (especially intravenous boluses of
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         ) [
         <a href="#rid62">
          62
         </a>
         ]. However, the precise interplay between cardiopulmonary diseases and anaphylaxis are unclear. (See
         <a class="medical medical_review" href="/z/d/html/386.html" rel="external">
          "Pathophysiology of anaphylaxis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h2">
          Upright posture during anaphylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulseless electrical cardiac activity has been identified at the time of death in some subjects with anaphylaxis, which is believed to result from inadequate cardiac filling during severe hypotension and subsequent cardiac arrest [
         <a href="#rid9">
          9,63,64
         </a>
         ]. The term "empty ventricle syndrome" has been applied to this phenomenon [
         <a href="#rid65">
          65
         </a>
         ]. Patients, caregivers, clinicians, and "first responders" must understand the importance of placing the patient in the supine position with legs elevated if signs of hypotension are present during an allergic reaction. (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment"
         </a>
         .)
        </p>
        <p>
         Conscious individuals with bronchospasm may resist being placed supine, as sitting upright may ease the sense of dyspnea. In this setting, providing oxygen and explaining the reason for lying down are important, at least until the cardiovascular status can be assessed. Individuals who are vomiting and also hypotensive should be placed on their side rather than supine.
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h2">
          Initial misdiagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaphylaxis can be mistaken for a variety of other conditions, such as asthma exacerbation, panic attack, myocardial infarction, and choking. In some cases, valuable time is lost or inappropriate medications are given before the correct diagnosis is recognized [
         <a href="#rid6">
          6,50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h2">
          Systemic mastocytosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with systemic mastocytosis may be at higher risk for fatal anaphylaxis, even in the absence of immunoglobulin E (IgE)-mediated allergy. In the United Kingdom register, 2 of 164 individuals had systemic mastocytosis [
         <a href="#rid6">
          6
         </a>
         ]. One died following a bee sting and the other died during anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/4784.html" rel="external">
          "Mastocytosis (cutaneous and systemic) in adults: Epidemiology, pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h2">
          Other atopic conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nearly all patients who died of anaphylaxis were known to have had one or more allergic conditions or were clearly atopic by retrospectively gathered history [
         <a href="#rid50">
          50
         </a>
         ]. Venom- and medication-induced anaphylaxis, however, typically afflict nonatopic individuals.
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h2">
          Exacerbating factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         The severity of anaphylaxis is believed to be increased in some cases by concurrent medications, foods, alcohol, exercise, premenstrual state, or other cofactors. These cofactors have been noted in both nonfatal and fatal anaphylaxis.
        </p>
        <p>
         Beta-blocking agents and angiotensin-converting enzyme inhibitors interfere with the pharmacologic treatment of and compensatory physiologic responses to anaphylaxis, respectively. The presence of these medications has been noted in some studies of venom-induced fatalities and experimental sting challenges [
         <a href="#rid66">
          66,67
         </a>
         ]. Patients taking these drugs, however, are not clearly over-represented in the literature on fatal anaphylaxis, and the impact of these medications requires further study.
        </p>
        <p>
         A variety of other medications, including
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         and other nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, alcohol, and antiulcer therapies, have been implicated in worsening the severity of anaphylaxis [
         <a href="#rid68">
          68
         </a>
         ]. These agents are occasionally reported as cofactors in fatal anaphylaxis [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h1">
          POSTMORTEM DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of fatal anaphylaxis is determined by the clinical presentation and historical information. Autopsy findings and laboratory testing may support the clinical impression, although they are not necessary or sufficient, in isolation, to make the diagnosis. In cases of sudden death of uncertain cause, femoral venous blood can be collected and the serum can be separated and frozen for later analysis [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H32">
         <span class="h2">
          Serum tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blood collected during or shortly after the event may be analyzed retrospectively for the mast cell-derived mediator tryptase and for evidence of immunoglobulin E (IgE) to the suspect allergen.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tryptase is a mediator released by mast cells upon activation and is relatively specific to this cell type, although basophils also make a small amount. Any elevation is consistent with anaphylaxis. Tryptase levels that are within normal limits do not exclude the diagnosis. Tryptase is seldom elevated in food-induced anaphylaxis. The use of postmortem tryptase levels in the evaluation of possible fatal anaphylaxis is reviewed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/389.html" rel="external">
          "Laboratory tests to support the clinical diagnosis of anaphylaxis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Quantitative IgE immunoassays may be helpful in detecting the presence of allergen-specific IgE in the victim's serum as a means of confirming that the patient was allergic to the allergen in question. Serum IgE levels do not change substantively as a result of anaphylaxis. Positive tests for allergen-specific IgE suggest the presence of sensitization. Negative assays do not exclude sensitization. Serum tests for sensitization to allergens are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/5540.html" rel="external">
          "Overview of in vitro allergy tests"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In one retrospective review, there were 56 cases of fatal anaphylaxis in which autopsy information was available [
         <a href="#rid51">
          51
         </a>
         ]. Of these, 21, 19, and 16 fatalities were due to medications, insect venoms, and food allergies, respectively. Laboratory test results were not available in most cases. However, in the 16 cases of fatal anaphylaxis (due to a variety of agents) in which tryptase levels were measured, elevations were found in 14. In a series of 25 selected cases of fatal anaphylaxis, serum total tryptase concentrations were elevated in 4 of 7 cases tested [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H33">
         <span class="h2">
          Autopsy findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many victims have no distinguishing gross pathologic features at autopsy, particularly if shock develops rapidly [
         <a href="#rid10">
          10,27,51
         </a>
         ]. When present, however, findings include upper airway edema, mucus plugging and hyperinflation of the lungs, and cerebral edema [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         In the series of 56 cases mentioned previously, all individuals collapsed after allergen exposure, and 23 had a documented asthmatic component [
         <a href="#rid51">
          51
         </a>
         ]. Dermatologic signs and symptoms were uncommon. The following macroscopic findings were reported:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laryngeal or pharyngeal edema (41 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hyperinflation of the lungs and/or mucus plugging (27 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerebral edema, suggesting cerebral hypoxia (27 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Petechial hemorrhages in the airway mucosa, suggesting asphyxiation (18 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cutaneous erythema or urticaria (5 percent)
        </p>
        <p>
        </p>
        <p>
         In cases where anaphylaxis to food is suspected at the time of death, the pathologist can be asked to preserve some of the stomach contents for later analysis for suspected food allergens.
        </p>
        <p class="headingAnchor" id="H34">
         <span class="h1">
          PREVENTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The literature provides some insight into predicting which individuals are at greatest risk for fatal anaphylaxis. These individuals most often have allergy to foods, medications, or insect venoms, accompanied by one or more of the following characteristics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Concomitant asthma, particularly patients with food allergy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Comorbid cardiovascular conditions, particularly older patients
        </p>
        <p>
        </p>
        <p>
         Thus, clinicians should be mindful of classic patient profiles, such as young patients with food allergy and asthma or older patients with insect sting or medication allergies and cardiopulmonary diseases. Such high-risk patients should be supplied with and trained to use
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         autoinjectors. Clinicians should repeatedly reinforce important concepts in anaphylaxis preparedness  (
         <a class="graphic graphic_table graphicRef68300" href="/z/d/graphic/68300.html" rel="external">
          table 3
         </a>
         ). Careful attention to asthma control may reduce risk. (See
         <a class="medical medical_review" href="/z/d/html/388.html" rel="external">
          "Prescribing epinephrine for anaphylaxis self-treatment"
         </a>
         .)
        </p>
        <p>
         Prevention of anaphylactic deaths in patients that are not known to have an allergy is a public health issue that will need to be addressed by campaigns to improve public awareness of anaphylaxis and specific protocols for first responders [
         <a href="#rid70">
          70
         </a>
         ]. Similar approaches have been applied to community management of myocardial infarction, stroke, and choking. Anaphylaxis is rare compared with these events, although it often afflicts otherwise healthy people in the prime of life and is generally responsive to proper treatment.
        </p>
        <p class="headingAnchor" id="H361255023">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/105526.html" rel="external">
          "Society guideline links: Anaphylaxis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H35">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/368.html" rel="external">
          "Patient education: Anaphylaxis symptoms and diagnosis (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/372.html" rel="external">
          "Patient education: Anaphylaxis treatment and prevention of recurrences (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H36">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anaphylaxis is rare, although estimates of incidence are probably lower than the true figures. Anaphylaxis is believed fatal in up to 2 percent of cases. (See
         <a class="local">
          'Incidence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The most common causes of fatal anaphylaxis are foods, medications, and insect stings. (See
         <a class="local">
          'Etiologies and at-risk groups'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adolescents and young adults are at highest risk for fatal anaphylaxis induced by foods. Middle-aged and older adults account for most fatalities from venom- and medication-induced reactions. There are no clear differences between sexes or among racial groups. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Most patients with food-induced deaths were aware of the allergy and were supposed to be avoiding the culprit food. However, many had experienced only minor past reactions. Some patients with venom and medication reactions had no recognized reactions in the past. (See
         <a class="local">
          'Previous reactions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fatal anaphylaxis typically results in death within 30 to 60 minutes. The amount of allergen is usually unremarkable (eg, variable amounts of food, one insect sting, a normal dose of medication). (See
         <a class="local">
          'Timing'
         </a>
         above and
         <a class="local">
          'Allergen dose'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Most fatal food-induced reactions involve difficulty breathing and culminate in respiratory arrest. In contrast, venom- or medication-induced anaphylaxis more often cause shock and cardiovascular collapse. (See
         <a class="local">
          'Mechanism of death'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Concomitant asthma is a significant risk factor for fatal anaphylaxis, particularly for adolescents with food allergy. Older victims of anaphylaxis (from all causes) often have underlying cardiopulmonary conditions. (See
         <a class="local">
          'Possible risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Characteristics of unsuccessful treatment include delayed or no administration of
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         , either due to initial misdiagnosis, failure to properly administer epinephrine, or unavailability of this drug. Maintaining the patient in an upright position after collapse can lead to pulseless electrical activity and cardiac arrest (empty ventricle syndrome). Occasionally, victims succumb despite receiving prompt and appropriate treatment. (See
         <a class="local">
          'Possible risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnosis of fatal anaphylaxis is based upon clinical features and historical information, supported by laboratory and autopsy findings. Femoral venous blood can be collected and the serum separated and frozen for later assays of tryptase and allergen-specific immunoglobulin E (IgE). Autopsy findings may be minimal. (See
         <a class="local">
          'Postmortem diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fatal anaphylaxis is unpredictable, although certain patients are at higher risk, such as those with concomitant asthma or cardiopulmonary disease. Clinicians should optimize asthma control and repeatedly reinforce important issues regarding anaphylaxis preparedness  (
         <a class="graphic graphic_table graphicRef68300" href="/z/d/graphic/68300.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Prevention'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60:443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: A review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108:861.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simons FE, Ardusso LR, Dimov V, et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013; 162:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon MR, Mulla ZD. A population-based epidemiologic analysis of deaths from anaphylaxis in Florida. Allergy 2008; 63:1077.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 2014; 133:1075.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moneret-Vautrin DA, Kanny G, Morisset M, et al. Severe food anaphylaxis: 107 cases registered in 2002 by the Allergy Vigilance Network. Eur Ann Allergy Clin Immunol 2004; 36:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004; 4:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mullins RJ, Wainstein BK, Barnes EH, et al. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy 2016; 46:1099.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Low I, Stables S. Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005. Pathology 2006; 38:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations. J Allergy Clin Immunol 2014; 134:1318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pouessel G, Claverie C, Labreuche J, et al. Fatal anaphylaxis in France: Analysis of national anaphylaxis data, 1979-2011. J Allergy Clin Immunol 2017; 140:610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kivistö JE, Dunder T, Protudjer JL, et al. Adult but no pediatric anaphylaxis-related deaths in the Finnish population from 1996 to 2013. J Allergy Clin Immunol 2016; 138:630.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000; 320:1441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001; 31:1571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colver AF, Nevantaus H, Macdougall CF, Cant AJ. Severe food-allergic reactions in children across the UK and Ireland, 1998-2000. Acta Paediatr 2005; 94:689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol 2015; 135:956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turner PJ, Jerschow E, Umasunthar T, et al. Fatal Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Pract 2017; 5:1169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foucard T, Malmheden Yman I. A study on severe food reactions in Sweden--is soy protein an underestimated cause of food anaphylaxis? Allergy 1999; 54:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz HJ, Yunginger JW, Schwartz LB. Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy 1995; 25:866.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999; 353:1157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gruchalla RS. 10. Drug allergy. J Allergy Clin Immunol 2003; 111:S548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Srinivasa MR, Phelan C. Death due to anaphylactic shock after ingestion of Imodium instants (Loperamide). Allergy 2007; 62:965.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fasting S, Gisvold SE. [Serious intraoperative problems--a five-year review of 83,844 anesthetics]. Can J Anaesth 2002; 49:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993; 92:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernstein DI, Wanner M, Borish L, et al. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004; 113:1129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007; 98:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119:1016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992; 327:380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey RS, Stanworth SJ. The clinical spectrum of anaphylaxis in north-west England. Clin Exp Allergy 1996; 26:1364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy MB, Goldberg MR, Nachshon L, et al. Lessons from cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergen. Isr Med Assoc J 2012; 14:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noma T, Yoshizawa I, Ogawa N, et al. Fatal buckwheat dependent exercised-induced anaphylaxis. Asian Pac J Allergy Immunol 2001; 19:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flannagan LM, Wolf BC. Sudden death associated with food and exercise. J Forensic Sci 2004; 49:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sampson MA, Muñoz-Furlong A, Sicherer SH. Risk-taking and coping strategies of adolescents and young adults with food allergy. J Allergy Clin Immunol 2006; 117:1440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Upton J, Alvaro M, Nadeau K. A perspective on the pediatric death from oral food challenge reported from the Allergy Vigilance Network. Allergy 2019; 74:1035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           More DR, Kohlmeier RE, Hoffman DR. Fatal anaphylaxis to indoor native fire ant stings in an infant. Am J Forensic Med Pathol 2008; 29:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johansson B, Eriksson A, Ornehult L. Human fatalities caused by wasp and bee stings in Sweden. Int J Legal Med 1991; 104:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harvey P, Sperber S, Kette F, et al. Bee-sting mortality in Australia. Med J Aust 1984; 140:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mosbech H. Death caused by wasp and bee stings in Denmark 1960-1980. Allergy 1983; 38:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973; 52:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffman DR. Fatal reactions to hymenoptera stings. Allergy Asthma Proc 2003; 24:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ji KM, Li M, Chen JJ, et al. Anaphylactic shock and lethal anaphylaxis caused by Houttuynia Cordata injection, a herbal treatment in China. Allergy 2009; 64:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gangemi S, Spagnolo EV, Cardia G, Minciullo PL. Fatal anaphylactic shock due to a dental impression material. Int J Prosthodont 2009; 22:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Minciullo PL, Spagnolo EV, Cascio A, et al. Fatal anaphylactic shock and Taenia solium infestation: a possible link? Ann Allergy Asthma Immunol 2009; 103:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zimmerman B, Urch B. Peanut allergy: children who lose the positive skin test response. J Allergy Clin Immunol 2001; 107:558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ownby DR, Tomlanovich M, Sammons N, McCullough J. Anaphylaxis associated with latex allergy during barium enema examinations. AJR Am J Roentgenol 1991; 156:903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 2003; 33:1033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006; 97:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 2004; 257:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000; 53:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lantner R, Reisman RE. Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis. J Allergy Clin Immunol 1989; 84:900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lenler-Petersen P, Hansen D, Andersen M, et al. Drug-related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995; 48:1185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yocum MW, Khan DA. Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc 1994; 69:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000; 106:762.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sampson HA, Muñoz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown SG. Anaphylaxis: clinical concepts and research priorities. Emerg Med Australas 2006; 18:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007; 119:1018.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004; 113:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sasvary T, Müller U. [Fatalities from insect stings in Switzerland 1978 to 1987]. Schweiz Med Wochenschr 1994; 124:1887.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007; 7:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005; 5:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kudoh O, Warabi K, Yamaguchi K, et al. [A case of anaphylactic shock in an elderly man following protamine sulfate administration during emergent off-pump coronary artery bypass grafting]. Masui 2006; 55:605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ober AI, MacLean JA, Hannaway PJ. Life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor. J Allergy Clin Immunol 2003; 112:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hepner MJ, Ownby DR, Anderson JA, et al. Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. J Allergy Clin Immunol 1990; 86:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujita H, Osuna H, Kanbara T, et al. [Wheat anaphylaxis enhanced by administration of acetylsalicylic acid or by exercise]. Arerugi 2005; 54:1203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shen Y, Li L, Grant J, et al. Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006. Forensic Sci Int 2009; 186:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy KR, Hopp RJ, Kittelson EB, et al. Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs. Ann Allergy Asthma Immunol 2006; 96:398.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 390 Version 18.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15727574" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Epidemiology of life-threatening and lethal anaphylaxis: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11692116" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Emergency department anaphylaxis: A review of 142 patients in a single year.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24008815" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18547290" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A population-based epidemiologic analysis of deaths from anaphylaxis in Florida.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24332862" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Case fatality and population mortality associated with anaphylaxis in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10931122" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Lessons for management of anaphylaxis from a study of fatal reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15061394" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Severe food anaphylaxis: 107 cases registered in 2002 by the Allergy Vigilance Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15238794" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Anaphylaxis: can we tell who is at risk of a fatal reaction?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27144664" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Increases in anaphylaxis fatalities in Australia from 1997 to 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16916722" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25280385" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28283420" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Fatal anaphylaxis in France: Analysis of national anaphylaxis data, 1979-2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27343204" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Adult but no pediatric anaphylaxis-related deaths in the Finnish population from 1996 to 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10827045" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Hospital admissions for acute anaphylaxis: time trend study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11678857" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16188770" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Severe food-allergic reactions in children across the UK and Ireland, 1998-2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25468198" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28888247" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Fatal Anaphylaxis: Mortality Rate and Risk Factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10321562" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : A study on severe food reactions in Sweden--is soy protein an underestimated cause of food anaphylaxis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8564725" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Is unrecognized anaphylaxis a cause of sudden unexpected death?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10209990" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Under-reporting of antibiotic anaphylaxis may put patients at risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12592301" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : 10. Drug allergy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17620078" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Death due to anaphylactic shock after ingestion of Imodium instants (Loperamide).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12067864" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : [Serious intraoperative problems--a five-year review of 83,844 anesthetics].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8335856" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Survey of fatalities from skin testing and immunotherapy 1985-1989.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15208595" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17378256" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Fatal anaphylaxis: postmortem findings and associated comorbid diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11150011" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Fatalities due to anaphylactic reactions to foods.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17306354" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Further fatalities caused by anaphylactic reactions to food, 2001-2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1294076" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Fatal and near-fatal anaphylactic reactions to food in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9027436" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The clinical spectrum of anaphylaxis in north-west England.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22624439" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Lessons from cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12009078" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Fatal buckwheat dependent exercised-induced anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15171174" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Sudden death associated with food and exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16751011" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Risk-taking and coping strategies of adolescents and young adults with food allergy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30893474" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : A perspective on the pediatric death from oral food challenge reported from the Allergy Vigilance Network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19749619" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Fatal anaphylaxis to indoor native fire ant stings in an infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2054310" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Human fatalities caused by wasp and bee stings in Sweden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6694624" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Bee-sting mortality in Australia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6846747" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Death caused by wasp and bee stings in Denmark 1960-1980.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4746790" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Studies of 400 Hymenoptera sting deaths in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12776446" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Fatal reactions to hymenoptera stings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19210362" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Anaphylactic shock and lethal anaphylaxis caused by Houttuynia Cordata injection, a herbal treatment in China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19260424" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Fatal anaphylactic shock due to a dental impression material.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19938249" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Fatal anaphylactic shock and Taenia solium infestation: a possible link?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11240965" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Peanut allergy: children who lose the positive skin test response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2017949" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Anaphylaxis associated with latex allergy during barium enema examinations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12911775" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Anaphylaxis: risk factors for recurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16892779" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Anaphylaxis: a review of 601 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15025395" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Fatal anaphylaxis in the UK, 1992-2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10823122" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Postmortem findings after fatal anaphylactic reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2600324" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7636523" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Drug-related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the Committee on Adverse Drug Reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7903730" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Assessment of patients who have experienced anaphylaxis: a 3-year survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3722636" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Biphasic and protracted anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11015520" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Biphasic anaphylactic reactions in pediatrics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15753908" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Symposium on the definition and management of anaphylaxis: summary report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16669942" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Anaphylaxis: clinical concepts and research priorities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17349682" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Further fatal allergic reactions to food in the United Kingdom, 1999-2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15131564" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : First-aid treatment of anaphylaxis to food: focus on epinephrine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7973516" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : [Fatalities from insect stings in Switzerland 1978 to 1987].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17620826" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Cardiovascular disease and anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15985820" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16715917" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : [A case of anaphylactic shock in an elderly man following protamine sulfate administration during emergent off-pump coronary artery bypass grafting].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12897756" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Fatal posture in anaphylactic shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14610496" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1976666" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16407667" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : [Wheat anaphylaxis enhanced by administration of acetylsalicylic acid or by exercise].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19217731" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16597073" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
